focus -WSS

focus

author：leisure time 2025-09-29 23:27:55 - browse：3348

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

leisure time

entertainment

WSS

What will Novo Nordisk's VC do with its influx of cash?

Some top drug companies are starting to take action on climate

Biotech lab space demand falls sharply

Lasker Awards 2023: Winners in biomedical research

How AI helped researchers track recovery from depression

Setback for rare diseases as Taysha Gene Therapies pulls back

hotspot

focus

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

What will Novo Nordisk's VC do with its influx of cash?

Continuity nursing helped my family in our darkest PICU moments

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Cancer drug shortages should be causing more outrage

The Karikó problem: Lessons for funding basic research

Moonlake's readout produced a cash windfall. Risks remain

Will an HIV vaccine ever be a reality?

Virginia high school admissions case could be legal follow

Why are Kaiser Permanente staff considering a strike?

explore

FDA panel to weigh approval of NurOwn, controversial ALS drug

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

The Karikó problem: Lessons for funding basic research

What we owe ALS patients — and why one company fell short

How AI helped researchers track recovery from depression

Lasker Awards 2023: Winners in biomedical research

focus

leisure time

entertainment

knowledge